Axitinib or Bevacizumab Plus FOLFIRI or Modified FOLFOX-6 After Failure of First-Line Therapy for Metastatic Colorectal Cancer: A Randomized Phase II Study-Reference-Cited by-同舟云学术

Axitinib or Bevacizumab Plus FOLFIRI or Modified FOLFOX-6 After Failure of First-Line Therapy for Metastatic Colorectal Cancer: A Randomized Phase II Study

Published:2013-12 Issue:4 Volume:12 Page:239-247
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Bendell Johanna C.,Tournigand Christophe,Swieboda-Sadlej Anna,Barone Carlo,Wainberg Zev A.,Kim Jong Gwang,Pericay Carles,Pastorelli Davide,Tarazi Jamal,Rosbrook Brad,Bloom Joanna,Ricart Alejandro D.,Kim Sinil,Sobrero Alberto F.

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference22 articles.

1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology™ Colon Cancer v.3. January 2012. Available at: http://www.nccn.org/index.asp. Accessed June 12, 2012.

2. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study;Tournigand;J Clin Oncol,2004

3. Systemic therapy for metastatic colorectal cancer: patterns of chemotherapy and biologic therapy use in US medical oncology practice;Hess;J Oncol Pract,2010

4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

5. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200;Giantonio;J Clin Oncol,2007

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Irinotecan plus raltitrexed as second‑line chemotherapy for metastatic colorectal cancer: A retrospective study;Oncology Letters;2024-06-28

2. Blood Vessel-Targeted Therapy in Colorectal Cancer: Current Strategies and Future Perspectives;Cancers;2024-02-22

3. Clinical outcomes of chemotherapy-based therapies for previously treated advanced colorectal cancer: a systematic literature review and meta-analysis;International Journal of Colorectal Disease;2023-01-11

4. Response to BRAF-targeted Therapy Is Enhanced by Cotargeting VEGFRs or WNT/β-Catenin Signaling in BRAF-mutant Colorectal Cancer Models;Molecular Cancer Therapeutics;2022-10-05

5. A Quassinoid Diterpenoid Eurycomanone from Eurycoma longifolia Jack Exerts Anti-Cancer Effect through Autophagy Inhibition;Molecules;2022-07-08